
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1042 | 1033 | 966 | 850 | 1156 | 1988 |
Fund Return | 4.24% | 3.29% | -3.44% | -5.26% | 2.95% | 7.11% |
Place in category | 42 | 47 | 59 | 17 | 13 | 4 |
% in Category | 59 | 52 | 70 | 20 | 19 | 5 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lupus alpha Smaller German Champioa | 464.31M | 4.19 | -5.70 | 6.49 | ||
Lupus alpha Micro Champions Acc | 118.29M | -0.67 | -11.93 | 10.84 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lupus alpha Smaller German Champioa | 464.31M | 4.19 | -5.70 | 6.49 | ||
Deka Deutschland Nebenwerte CF | 255.12M | 4.46 | -5.73 | 5.43 | ||
MainFirst Germany Fund A | 106.31M | 3.72 | -5.91 | 5.05 | ||
MainFirst Germany Fund B | 106.31M | 3.72 | -5.91 | 4.90 | ||
MainFirst Germany Fund C | 106.31M | 3.77 | -5.40 | 5.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Redcare Pharmacy NV | NL0012044747 | 3.52 | 121.000 | +4.49% | |
Fresenius Medical Care | DE0005785802 | 3.36 | 44.895 | +1.53% | |
Puma SE | DE0006969603 | 3.19 | 30.04 | +0.13% | |
Fuchs SE Participating Preferred | DE000A3E5D64 | 3.02 | - | - | |
Knorr-Bremse | DE000KBX1006 | 2.60 | 84.65 | +1.68% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Sell |
Summary | Strong Buy | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review